Contact this trialFirst, we need to learn more about you.
KRAS G12C Inhibitor
Adagrasib + SRS for Lung Cancer with Brain Metastases
Recruiting1 awardPhase 2
Charlottesville, Virginia
"This trial will test the effectiveness of a combination treatment of SRS and adagrasib for patients with a specific type of lung cancer that has spread to the brain. 30 patients will participate in
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service